Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)

NCT00442897 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: simvastatin (+) ezetimibe
DRUG: Comparator: atorvastatin

Sponsor

Organon and Co